Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02551770 · ClinicalTrials.gov registry record · NA
Emdogain Minimally Invasive Surgical Technique
A NA study, sponsored by Institut Straumann.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT02551770: Completed NA study, sponsored by Institut Straumann.
NCT02551770 is a NA study that has completed, run by Institut Straumann. The registered enrollment target is 51 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02551770, a NA study, has completed, sponsored by Institut Straumann.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
The aim of this controlled study is to assess the clinical outcomes and patient reported outcomes of using minimally invasive surgical procedure with Straumann Emdogain as an adjunct (test treatment) or without Straumann Emdogain (control treatment).
Primary Outcome
CAL will be measured in millimeters on the study teeth at 6 locations. Outcome is mean change of CAL from baseline measurements at surgery to 12-months post-surgery, taken from the deepest pocket of a patient's test and control teeth measured at baseline. Analysis will compare the mean change of CAL for test and control treatment arms.
Interventions
- PROCEDURE Scaling and root planing
- PROCEDURE Scaling and root planing without Emdogain
- DEVICE Emdogain application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2015-10 |
| Est. Completion | 2019-08-30 |
| Phase | NA |
What the finished NCT02551770 record still lists
NCT02551770 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Scaling and root planing is the first listed.
NCT02551770 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02551770 about?
NCT02551770 is a clinical study titled "Emdogain Minimally Invasive Surgical Technique". The aim of this controlled study is to assess the clinical outcomes and patient reported outcomes of using minimally invasive surgical procedure with Straumann Emdogain as an adjunct (test treatment) or without Straumann Emdogain (control treatment).
What is the current status of trial NCT02551770?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2015-10. Estimated completion is 2019-08-30.
What interventions are being tested in trial NCT02551770?
The interventions under investigation include: Scaling and root planing (PROCEDURE), Scaling and root planing without Emdogain (PROCEDURE), Emdogain application (DEVICE).
Who is sponsoring clinical trial NCT02551770?
This trial is sponsored by Institut Straumann, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02551770's enrollment target sits among peer trials
51 1279th of 2000 higher than 722 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia